Daily News Podcast

Opioids don’t top NSAIDs for chronic pain


 

Opioids’ pain relief and physical function benefits don’t top NSAIDs in chronic noncancer pain. A barbershop-based hypertension intervention is still going strong a year later. Canakinumab has a remarkable effect on knee and hip replacement risk. And low-tech BMI compares favorably with body scanning for cardiometabolic screening.

Amazon Alexa

Apple Podcasts

Google Podcasts

Spotify

Recommended Reading

Sprain an ankle, get an opioid
MDedge Hematology and Oncology
Physician burnout singes patient safety
MDedge Hematology and Oncology
Confirmed: Growth in overdose deaths is exponential
MDedge Hematology and Oncology
House, Senate agree on broad opioid legislation
MDedge Hematology and Oncology
Does America have a gabapentinoid problem?
MDedge Hematology and Oncology
Opioid use cut nearly 50% for urologic oncology surgery patients
MDedge Hematology and Oncology
Palliative care update highlights role of nonspecialists
MDedge Hematology and Oncology
Use of smartphone app improves pain outcomes
MDedge Hematology and Oncology
Opioids appear safe for sickle cell pain
MDedge Hematology and Oncology
Insulin loses its starting spot
MDedge Hematology and Oncology